Central government debt continues to increase and a new 17-year bond loan is to be launched
October 22, 2003 03:30 ET | Riksgälden
The borrowing requirement in 2003The Debt Office's forecast of the borrowing requirement in 2003 indicates a deficit in central government payments of SEK 45 billion, which is SEK 18 billion more than...
Statsskulden fortsätter att öka och en ny 17-årig obligation lanseras
October 22, 2003 03:30 ET | Riksgälden
Lånebehovet 2003 Lånebehovet 2003 pekar på ett underskott i statens betalningar på 45 miljarder kronor, vilket är 18 miljarder kronor mer än i vår juniprognos. Lånebehovet under perioden juni till...
Elekta's revolution encourages radiotherapy evolution
October 22, 2003 03:23 ET | Elekta
STOCKHOLM, Sweden, Oct. 22, 2003 (PRIMEZONE) -- Exciting data presented today at the American Society for Therapeutic Radiology and Oncology (ASTRO) annual meeting, demonstrate the enormous...
Bure participates in new share issue in Dimension
October 22, 2003 03:13 ET | Bure Equity
GOTHENBURG, Sweden, Oct. 22, 2003 (PRIMEZONE) -- Bure Equity (Other OTC:BRVVF): Dimension's Board of Directors has decided to implement a new share issue for approximately SEK 40M with a right of...
Aker Kvaerner wins contract for two pure terephthalic acid plants
October 22, 2003 03:11 ET | Akastor ASA
The contract, valued between USD170-180 million, will be led from Aker Kvaerner's Solent office in the United Kingdom. The scope of work comprises basic engineering, the supply of offshore equipment...
Gambro chosen for Dow Jones Sustainability World Index
October 22, 2003 03:02 ET | Gambro
STOCKHOLM, Sweden, Oct. 22, 2003 (PRIMEZONE) -- Gambro AB (OtherOTC:GAMOF) (Other OTC:GAMBF), a leading international medical technology and healthcare company, today announced that it has been...
OM HEX Interim Report January - September 2003
October 22, 2003 02:30 ET | OMX
STOCKHOLM, Sweden, Oct. 22, 2003 (PRIMEZONE) -- OMHEX (Other OTC:OMGPF) -- Revenue amounted to SEK 1 936 m (1 996) during January-September 2003 -- Operating income excluding items affecting...
Crucell Announces Malaria Vaccine Program in Collaboration with New York University, Walter Reed Army Institute of Research and GlaxoSmithKline
October 22, 2003 02:15 ET | Crucell N.V.
LEIDEN, The Netherlands, Oct. 22, 2003 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) announced today that its vaccine candidate against malaria will undergo...
SEB Interim Report J
SEB Interim Report January-September 2003
October 22, 2003 02:01 ET | SEB
Operating result for the third quarter isolated amounted to SEK 2,004m, slightly better than the previous quarter and 29 per cent higher than the third quarter of 2002 Operating result for the...
SEB Delårsrapport ja
SEB Delårsrapport januari-september 2003
October 22, 2003 02:00 ET | SEB
Rörelseresultatet för tredje kvartalet uppgick till 2 004 Mkr, en liten ökning jämfört med det föregående kvartalet och 29 procent bättre än resultatet för tredje kvartalet 2002 Rörelseresultatet...